Saba Ghodrati

National Institute of Health, Bethesda, MD, United States 
Behavioral pharmacology
"Saba Ghodrati"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jain A, Stack O, Ghodrati S, et al. (2023) encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression. Proceedings of the National Academy of Sciences of the United States of America. 120: e2214700120
Minervini V, Tye CB, Ghodrati S, et al. (2021) Effects of remifentanil/histamine mixtures in rats responding under a choice procedure. Behavioural Pharmacology
Gerak LR, Minervini V, Latham E, et al. (2019) Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of µ opioid receptor agonists but not prolonged precipitated withdrawal in rats. The Journal of Pharmacology and Experimental Therapeutics
See more...